Molecular basis of the spectrum of skeletal complications of neoplasia.
about
Discoveries, drugs and skeletal disorders.The use of bisphosphonates in patients with breast cancer.Physiopathology of spine metastasis.Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysisHypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to boneProteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.Pthlh, a promising cancer modifier gene in rat tongue carcinogenesisETS transcription factors and targets in tumour invasion, angiogenesis and bone metastasis.Osteolysis and cancer.Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo.Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor–κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton
P2860
Q34932153-E830D4DC-8204-41EA-A908-4325B3F1D7B7Q35039488-8D070E7F-B7EE-43D9-9F7F-7409FEA2D9E6Q35692236-1D6940CB-8F3B-4788-A9E7-1A845E81283DQ35843398-2980C2DA-39A2-4102-A63E-2CA0F270BE85Q36072569-DE211067-DCE6-4A7D-8437-9156D35180CEQ36519704-DEE8DDD7-6EBF-41C3-B902-01EA8E39D2DFQ36707418-D498B7FF-09D0-4C6D-8D2A-825D827EE947Q37404551-14D5E502-BBE1-4D89-A841-7356898BF4A2Q38324197-040E4296-17F5-475D-8B17-098191789B7CQ39946675-B89FD925-27D6-4529-9F8E-0669B3DEDE39Q41497465-26A17F61-EFA4-4830-904C-8F73F8967F2BQ41712371-1B2D5F7F-017A-42D1-BF1D-A8053EAF6828Q41873508-35F79AB6-69ED-4C8D-AF17-96E8ABA9919AQ57904787-4D9F7AC3-C1C5-4B3F-AE7D-D822C89652F9
P2860
Molecular basis of the spectrum of skeletal complications of neoplasia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular basis of the spectrum of skeletal complications of neoplasia.
@ast
Molecular basis of the spectrum of skeletal complications of neoplasia.
@en
type
label
Molecular basis of the spectrum of skeletal complications of neoplasia.
@ast
Molecular basis of the spectrum of skeletal complications of neoplasia.
@en
prefLabel
Molecular basis of the spectrum of skeletal complications of neoplasia.
@ast
Molecular basis of the spectrum of skeletal complications of neoplasia.
@en
P2093
P2860
P1433
P1476
Molecular basis of the spectrum of skeletal complications of neoplasia.
@en
P2093
Goltzman D
Karaplis AC
Rabbani SA
P2860
P304
P356
10.1002/1097-0142(20000615)88:12+<2903::AID-CNCR4>3.0.CO;2-G
P407
P433
P577
2000-06-01T00:00:00Z